Skip to main content
. Author manuscript; available in PMC: 2016 Sep 15.
Published in final edited form as: Adv Mater. 2015 Sep 21;28(6):1295–1301. doi: 10.1002/adma.201502660

Figure 1. Three examples of co-delivery systems based on the LbL technique.

Figure 1

(A) LbL liposomal nanoparticles (LbL-LNPs) manufactured for a dual-drug delivery system with doxorubicin (DOX) loaded into the core and mitoxantrone (MTX) on to the shell layers;[30] (B) LbL degradable polymer coatings on AuNPs for the simultaneous co-delivery of DNA and siRNA;[31] (C) The co-delivery of siRNA and doxorubicin using the modular DOX-liposome/PLA/siRNA/PLA/HA LbL nanoparticle platform (Left); Release profile of the two therapeutic components (Right).[25]